Myocardial infarction (MI) is a prevalent cause of mortality
worldwide.
In this study, a sandwich scaffold was prepared for MI therapy using
two commonly used materials in the medical field, polyglycerol sebacate
(PGS) and polycaprolactone (PCL), and a series of interrelated steps.
The PGS/PCL nanofibers were coated with a conductive polymer, i.e.,
polypyrrole (PPy), and then embedded into a decellularized myocardium
gel to form a 3D scaffold. Different quantitative and qualitative
evaluation tests were performed, and their results were reported.
Under optimal conditions for nanofiber production, the PGS/PCL/PPy
nanofibers had an average diameter of 411 nm with electrical conductivity
0.00108 S cm–1. The hydrophilicity of the PGS/PCL
layer did not significantly change after coating with PPy. The biodegradability
test showed a reduction of 39% and 33% in weight for the uncoated
and PPy-coated samples, respectively, after 24 weeks. The highest
biocompatibility was observed in the sample synthesized with 0.05
M pyrrole. Histological assessments and DNA content tests validated
the process of decellularization. The highest cell viability was observed
in the scaffold containing a solubilized and decellularized myocardium
gel (PGS/PCL/PPyA/DMG) with evenly distributed cells on
the surface of the scaffolds. The highest cell infiltration and the
highest percentage of expression of the specific cardiac proteins
(Cx43, MHC, and cTnT) were also observed in the PGS/PCL/PPyA/DMG scaffold, which was attributed to the synergistic effect of
PPy and decellularized myocardium gel (p-value <0.001).